Same. Shoulder injuries never seem to end well. They always seem to lead to surgery or vastly diminished stuff for those who avoid it. Obviously hoping for the best, but any sort of shoulder injury never leaves me thinking things are going to come up roses in the end. That said, spending millions of dollars on Soriano because of a handful of games is a bit of a knee jerk reaction. He hasn't exactly been a shut down reliever himself for a couple years now. ERA's the past two seasons have been 3.11 and 3.19 with FIP's of 3.65 and 3.08. That's fine and well for a middle reliever, and certainly represents an upgrade over Schlitter and the like, but he's gonna ask for closer money, he's 35, and his velocity has gone down each year since 2009. It was 91.2 last year. If he continues the trend, I'd prefer to spend several million dollars on a guy who can consistently hit higher than that. He also barely threw his two seamer and cutter last season . He was primarily a 4 seamer and slider pitcher. According to Pitch f/x, when he was with the Rays and Yankees his cutter usage was up in the upper 40% and 50%. It was 5% last season. I doubt that was organizational philosophy (his last year with the Yankees, cutter usage was down to 11.4%, which carried over to his Nationals stint in 2013 [11.9%]). Pitch f/x says his cutter is still decent, but his slider has negative value (and has for the past 3 seasons), yet he's throwing his cutter less and his slider more. His cutter averaged 89.5 last season, perhaps the loss in velocity has led to a lack of faith in his cutter. Either way, he's basically a two pitch pitcher now, and only one of them is of any value (4 seamer). Yes, Soriano represents an upgrade over guys like Schlitter, but they are there because of some injuries to Grimm and Wada and Ramirez. While I'm not as optimistic about Ramirez, Grimm and Wada should have better odds for decent results (knock on wood), and Wada should be back very soon which will almost certainly remove Schlitter from the roster and get rid of one headache. We shouldn't throw in the towel and go to drastic measures like signing a 35 year old guy who is going to need to report to extended spring training for at least a week or so before getting back into game action for $10 mil if that's indeed what he's demanding. Let's see what Wada can do when he gets brought back, and wait for the returns on Grimm and/or Ramirez before looking for bullpen help. Perhaps by then Vogelbach has boosted his value up and he can be packaged with other expendables for a reliever if need be